Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
GMAB compared with BLTE: revenue, margins and what each company keeps, and the suppliers and customers both name
GMAB
Genmab A/S
Change
Mkt cap
Revenue
Revenue
BLTE
Belite Bio, Inc
Change
Mkt cap
Revenue
Revenue
vs
Compare
GMAB
Genmab A/S
vs
BLTE
Belite Bio, Inc
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
Supply-chain overlap
Revenue flow
GMAB: latest quarter not drawable. BLTE: latest quarter not drawable.
Method
›
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only GMAB
1
COAG
Hemab Therapeutics
customer
Shared
0
No shared counterparties.
Only BLTE
1
—
The Trustees of Columbia University in the City of New York
unlisted
supplier
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR
GMAB
Genmab A/S
Change
56.28
▲
+2.48%
Mkt cap
$36.7B
BLTE
Belite Bio, Inc
Change
152.00
▼
−1.09%
Regular session
Nov 3 '26
Mkt cap
$6.0B
vs
Compare
Regular session
Nov 3 '26
GMAB
Genmab A/S
vs
BLTE
Belite Bio, Inc
56.28
▲
+2.48%
Price
152.00
▼
−1.09%
$36.7B
Mkt cap
$6.0B
Change
Change
GMAB
56.28
▲
+2.48%
vs
BLTE
152.00
▼
−1.09%
Regular session
Nov 3 '26
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
GMAB, solid
BLTE, dashed